The University of New England welcomed the state’s top biomedical researchers in a celebration of world-class research …
Blog
UNE Students Receive Outstanding Poster Awards at the First Annual Maine Research Symposium on Biomedical Science and Engineering!
Outstanding Graduate Student Poster Award:Madison Mueth, GSBSE/UNE: “Sex differences in susceptibility to develop advanced osteoarthritis pain” …
“Causing Patients Harm: the real-world consequences of research misconduct” by Frank Chessa, P.hD. | Monday, November 14, 2022 | 12 – 1 PM
UNE Office of Research and Scholarship and MaineHealth Institute for Research present Responsible Conduct of Research …
UNE receives $6.6 million to study ocular pain!
The funding from the National Eye Institute will allow UNE researcher Ian Meng, Ph.D., and his …
RACISM Overcoming science’s toxic legacy
A Nature special issue, 20 October 2022 Science is “a shared experience, subject both to the best of …
A new paper co-authored by UNE’s Karen Houseknecht and Deborah Barlow in collaboration with senior author Adriano Mollica (Università degli Studi “G. d’Annunzio”, Chieti, IT) was published in ACS Medicinal Chemistry Letters on October 17,2022 “Discovery of κ Opioid Receptor (KOR)-Selective d-Tetrapeptides with Improved In Vivo Antinociceptive Effect after Peripheral Administration”
https://doi.org/10.1021/acsmedchemlett.2c00237
Interested in Research? Lunch & Learn with Bob Kennedy, August 2, 2022
https://une.zoom.us/rec/share/QhxGevQoEg943ZPa1xX1rlCoad-Kp-NNIYEfHq-2vIOV23XyIPJH4yBvS04PdbPd.rrZC2GDqrgLejy2d Password to access the video: 8ZCrv=0J
Introduction to RCR: Welcome to the Community of Scholars. Lunch & Learn with Karen Houseknecht, September 7, 2022
https://une.zoom.us/rec/share/o9uySULl7Q6PzkDlTpbEsaOreOc1xzoMrg1HL_AtWVJxBmHpS6Xf7yZ2QalE2Oh2.zkwCqPuIlWFZPVTg
NNE-CTR Seminar Series – Dr. Douglas Lowy from the National Cancer Institute “Restoring the Momentum in Cancer Prevention: HPV Initiatives” – October 28, 2022 from 12 – 1pm
This presentation will discuss the ability of the HPV vaccine, which was approved in 2006, to …